This brand name is authorized in Netherlands, South Africa
The drug SYNAPAUSE contains one active pharmaceutical ingredient (API):
|
1
Estriol
UNII FB33469R8E - ESTRIOL
|
|
Estriol is a steroid, a weak estrogen, specifically an agonist of the estrogen receptors ERα and ERβ. It is one of three major endogenous estrogens, the others being estradiol and estrone. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03CA04 | Estriol | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NL | Z-Index G-Standaard | Identifier(s): 14136899 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 17485, 18260, 20788, 24880 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 30/21.8/0152, V/18.6/201 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
